Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports

Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020

Paola Cristina Resende et al. Emerg Infect Dis. 2021 Jul.

Abstract

A 37-year-old healthcare worker from the northeastern region of Brazil experienced 2 clinical episodes of coronavirus disease. Infection with severe acute respiratory syndrome coronavirus 2 was confirmed by reverse transcription PCR in samples collected 116 days apart. Whole-genome sequencing revealed that the 2 infections were caused by the most prevalent lineage in Brazil, B.1.1.33, and the emerging lineage P.2. The first infection occurred in June 2020; Bayesian analysis suggests reinfection at some point during September 14-October 11, 2020, a few days before the second episode of coronavirus disease. Of note, P.2 corresponds to an emergent viral lineage in Brazil that contains the mutation E484K in the spike protein. The P.2 lineage was initially detected in the state of Rio de Janeiro, and since then it has been found throughout the country. Our findings suggest not only a reinfection case but also geographic dissemination of the emerging Brazil clade P.2.

Keywords: Brazil; COVID-19; P.2; SARS-CoV-2; coronavirus disease; reinfection; respiratory infections; secondary infection; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Maximum-likelihood tree of severe acute respiratory syndrome coronavirus 2 whole-genome sequences from Paraíba in study of reinfection case, Brazil, June–October 2020. Branching pattern of whole-genome sequences (29779 nt) from Paraíba (n = 77) are shown classified within lineages B.1.1.28 (red), B1.1.33 (blue), and others B.1.1 (black). Sequences derived from the primary infection and reinfection are highlighted with different colors as indicated. Nodes with high statistical support (approximate-likelihood ratio test >9.0) are marked by the smaller circular shapes.
Figure 2
Figure 2
Emergence of the P.2 clade in study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection case, Brazil. A) Maximum-likelihood phylogenetic tree of B.1.1.28 SARS-CoV-2 whole-genome sequences (29,779-nt) from Brazil (n = 376). Shaded box highlights the P.2 clade (n = 47), and its statistical support (approximate-likelihood ratio test = 1.0) is indicated in the cladogram. Sequences from Paraíba are indicated in orange and sequences from the reinfection case are indicated by green. B) Time-scaled Bayesian maximum clade credibility tree of SARS-CoV-2 whole-genome sequences from the P.2 clade (n = 47). Branches are colored according to the most probable location state of their descendent nodes as indicated. The 5 lineage-defining single-nucleotide polymorphisms are indicated at the maximum clade credibility tree root node. Circular shapes mark nodes with high statistical support (posterior probability>9.0), and a square tip shape indicates the sequence from reinfection case. AL, Alagoas; AM, Amazonas; PB, Paraíba; PR, Parana; RJ, Rio de Janeiro; UTR, untranslated region.

References

    1. Babiker A, Marvil CE, Waggoner JJ, Collins MH, Piantadosi A. The importance and challenges of identifying SARS-CoV-2 reinfections. J Clin Microbiol. 2021;59:e02769–20. - PMC - PubMed
    1. Brazilian Ministry of Health, Health Surveillance Secretariat. TECHNICAL NOTE Nº 52/2020-CGPNI/DEIDT/SVS/MS [in Portuguese]. In: Department of Immunization and Communicable Diseases. General Coordination of the National Immunization Program, editors. Bairro Asa Norte: Brazil DF; 2020. p. 4.
    1. National Institutes of Health. Clinical spectrum of SARS-CoV-2 infection. December 17, 2020. [cited 2021 Mar 29]. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum
    1. Biomanginhos FIOCRUZ. Kit Molecular SARS-CoV-2 (information and consultation of manuals) [in Portuguese] [cited 2020 Apr 15]. https://www.bio.fiocruz.br/index.php/br/produtos/reativos/testes-molecul...
    1. Food and Drug Administration. CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel [cited 2020 Dec 1]. https://www.fda.gov/media/134922/download - PMC - PubMed

Publication types